Litaba tsa indasteri
Tšebeliso ea nako e telele ea CD19 CAR T-Cell Therapy ho Phekolo ea Relapsed/Refractory Acute Lymphoblastic Leukemia.
Boithuto bo matla bo bonts'a katleho ea nako e telele ea CD19 CAR T-cell therapy ho alafa bakuli ba nang le lefu la ho khutla hape / refractory acute lymphoblastic leukemia (ALL) ka mor'a phetisetso ea li-allogeneic hematopoietic stem cell transplantation, e fanang ka tšepo e ncha ho hematology.
Tsoelo-pele e Tsoelang Pele Liseleng tsa 'Molai oa Tlhaho (NK) Ho feta Lilemo tse 50
Lilemong tse mashome a mahlano tse fetileng, lipatlisiso ka lisele tsa Natural Killer (NK) li fetotse kutloisiso ea rona ea ts'ireletso ea tlhaho ea 'mele, e fana ka mekhoa e mecha e tšepisang bakeng sa mofetše le kalafo ea vaerase.
Katleho ho Mafu a Ikemetseng a Bana: Phekolo ea Lisele ea CAR-T e Phekola Mokuli oa Lupus
Thuto ea bopula-maliboho Sepetleleng sa Univesithi ea Erlangen e atlehile ho phekola ngoanana ea lilemo li 16 ea nang le lefu le matla la systemic lupus erythematosus (SLE) a sebelisa CAR-T cell therapy. Sena se tšoaea tšebeliso ea pele ea kalafo ena bakeng sa lupus ea bana, e fanang ka tšepo e ncha bakeng sa bana ba nang le mafu a autoimmune.
Ho Ntlafatsa Katleho ea PROTAC: Thuto e Hlollang
Phuputso ea morao-rao ho Nature Communications e senola lintlha tse ka sehloohong tse mabapi le mekhoa ea matšoao e fetolang katleho ea ho senyeha ha protheine e lebisitsoeng ho sebelisoa li-PROTAC. Ho sibolloa hona ho ka bula tsela bakeng sa kalafo e sebetsang haholoanyane bakeng sa mofetše le mafu a mang.
Ho Khothalletsa Bophelo bo Botle le Pholiso: Tlhokomelo ea Letsatsi le Letsatsi bakeng sa Bakuli ba Leukemia
Ho netefatsa kalafo e bolokehileng le e phutholohileng bakeng sa bakuli ba lukemia ho kenyelletsa tlhokomelo e hlokolosi ea letsatsi le letsatsi, ho kenyeletsoa bohloeki ba tikoloho, bohloeki ba motho, phepo e nepahetseng, le boikoetliso bo nepahetseng. Tataiso ena e fana ka malebela a bohlokoa bakeng sa tlhokomelo e sebetsang ea letsatsi le letsatsi ho tšehetsa ho hlaphoheloa.
Liphetho tsa Groundbreaking tsa CD7-Targeted CAR-T Therapy bakeng sa T-ALL le T-LBL
Phuputso ea morao tjena e totobatsa liphello tse tšepisang tsa CD7-targeted chimeric antigen receptor (CAR) T cell therapy ho phekola bakuli ba nang le T-cell acute lymphoblastic leukemia (T-ALL) le T-cell lymphoblastic lymphoma (T-LBL)
Kakaretso ea Kopano ea Selemo le Selemo ea 2024 ASH le Ponahatso
Seboka sa Selemo sa Bo66 sa Mokhatlo oa Amerika oa Hematology (ASH) se tla tšoaroa ho tloha ka la 7-10 Tšitoe, 2024, Setsing sa Kopano sa San Diego, ho bonts'a lipatlisiso tse matla le tsoelo-pele ea hematology.
Tšepo e Ncha ea Kalafo ea Kankere: TILs Therapy Emerges as the Next Frontier
Ho sa tsotellehe mathata a tsoelang pele a indasteri le khoebo, mefokolo ea phekolo ea CAR-T e ntse e rarolloa ka mokhoa o mocha o tšepisang: Kalafo ea Tumor-Infiltrating Lymphocyte (TIL). Katleho ena e phatlalatsa mehla e mecha ea ntoa khahlanong le lihlahala tse tiileng.
Na Liphekolo tsa Mehala ke Bokamoso ba Boloetse ba Boiketlo ba 'mele?
Phekolo ea phetoho bakeng sa mofetše e ka boela ea khona ho phekola le ho tsosolosa sesole sa 'mele ho fana ka tšoarelo ea nako e telele kapa mohlomong le ho phekola maloetse a itseng a autoimmune.
